NIH Announces Funding Opportunities Related to ncRNAs in Cancer, Low-Abundance miRNAs | GenomeWeb

The National Institutes of Health announced this week a funding opportunity for research projects investigating microRNAs and other non-coding RNA as targets for cancer detection and prevention.

Specifically, the National Cancer Institute-sponsored program will finance research studying the role of miRNAs and ncRNAs in pre-neoplastic lesions and their potential utility in predicting progression to cancer. Also eligible for funding are projects determining whether small RNAs obtained from body fluids can be used for early cancer detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.